MUMBAI, India, May 29 -- Intellectual Property India has published a patent application (202641062347 A) filed by Adichunchanagiri University; and Adichunchanagiri Institute Of Medical Sciences, Mandya, Karnataka, on May 16, for 'cord blood liver enzyme profile among term asphyxiated and non asphyxiated newborns-a hospital based observational study.'
Inventor(s) include Dr. Praveen Kumar; and Dr. Krishnamurthy B.
The application for the patent was published on May 29, under issue no. 22/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to a novel cord blood biomarker-based diagnostic system and method for early assessment of hypoxic hepatitis and multi-organ injury in term neonates with birth asphyxia. This approach utilizes serial measurement of liver enzymes (ALT, AST, and LDH) in cord blood at birth and at 24 hours, combined with clinical parameters such as Apgar scores, HIE staging, and seizure occurrence, to provide a reliable, non-invasive biomarker profile for evaluating the severity of perinatal hypoxic-ischemic injury. By correlating enzyme elevations with clinical outcomes in asphyxiated versus non-asphyxiated neonates, the system enables rapid risk stratification, early identification of hepatic involvement, and timely intervention, addressing limitations of traditional clinical scoring systems that often delay recognition of organ dysfunction."
Disclaimer: Curated by HT Syndication.
